Conversion of recent-onset atrial fibrillation by a single oral dose of Pilsicainide (Pilsicainide suppression trial on atrial fibrillation)

American Journal of Cardiology

Volumn 78, Issue 6, 1996, Pages 694-697

  Atarashi, Hirotsugu ^a   Inoue, Hiroshi ^b   Hiejima, Kazumasa ^b   Hayakawa, Hirokazu ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DRUG DERIVATIVE; LIDOCAINE; PILSICAINIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030587230     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00401-8     Document Type: Article

References (17)

1. Margolis B, DeSilva R, Lown B. Episodic drug treatment in the management of paroxysmal arrhythmias. Am Heart J 1980;45:621-626.
2. Rose JS, Bhandari A, Rahimtoola SH, Wu D. Effective termination of reentrant supraventricular tachycardia by a single dose oral combination therapy with pidolol and verapamil. Am Heart J 1986;112:759-765.
3. Musto B, Cavallaro C, Musto A, D'Onofrio A, De Vincentis L. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults. Am Heart J 1992;124:110-115.
4. Capucci A, Lenzi T, Boriani G, Trisolino G, Binetti N, Cavazza M, Fontana G, Magnani B. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992;70:69-72.
5. Capucci A, Boriani G, Botto GL, Lenzi T, Rubino I, Falcone C, Trisolino G, Casa SD, Binetti N, Cavazza M, Sanguinetti M, Magnani B. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 1994;74:503-504.
6. Ino T, Atarashi H, Hayakawa H. Electrophysiologic and hemodynamic effects of SUN 1165, a new antiarrhythmic agent. In Toyama J, Hondeghem LM, eds. Current Topics in Antiarrhythmic Agents. Tokyo: Excerpta Medica, 1989:219-229.
7. Terazawa T, Suzuki M, Goto T, Kato R, Hayashi H, Ito A, Sotobata I. Suppressive effect of SUN 1165 on supraventricular tachycardia. Am Heart J 1991;121:1437-1444.
8. Atarashi H, Ino T, Hayakawa H. Electrophysiologic testing and effects of antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia. Jpn Circ J 1992;56(Suppl 5):1451-1453.
9. Sato S, Watanabe J, Keitoku M, Kinoshita H, Sekiguchi N, Endoh S, Ohtsuka K, Hangai K, Morita M, Takishima T. Effects of N-(2, 6-dimethylphenyl)-8-pyrrolizineacetamide hydrochloride hemihydrate on the ventriculo-atrial conductivity of accessory pathway. Arzneim-Forsch/Drug Res 1989;39:908-911.
10. Hattori Y, Inomata N, Aisaka K, Ishihara T. Electrophysiological actions of N-(2,6-dimemylphenyl)-8-pyrrolizmeacetamide hydrochloride hemihydrate (SUN1165), a new antiarrhythmic agent. J Cardiovasc Pharmacol 1986; 8:998-1002.
11. Inomata N, Ishihara T, Akaike T. SUN1165, a new antiarrhythmic Na current blocker in ventricular myocytes of guinea-pig. Comp Biochem Physiol 1987;87C:237-243.
12. Toyama J, Kodama I, Kusunoki T, Ishihara T, Hattori Y, Yamada K. Use-dependent blocking action of newly developed lidocaine-analogs on maximum rate of rise of action potentials in guinea pig papillary muscle. Jpn Heart J 1987;28:237-285.
13. Hattori Y, Hidaka T, Aisaka K, Satoh F, Ishihara T. Effect of SUN1165, a new potent antiarrhythmic agent, on the kinetics of the rate-dependent block of Na channels and ventricular conduction of extrasystoles. J Cardiovasc Pharmacol 1988;11:407-412.
14. Marcus FI. The hazards of using type Ic antiarrhythmic drugs for the treatment paroxysmal atrial fibrillation. Am J Cardiol 1990;66:366-367.
15. Feld GK, Chen PS, Nicod P, Fleck RP, Meyer D. Possible atrial proarrhythmic effects of class Ic antiarrhythmic drugs. Am J Cardiol 1990;66:378-383.
16. Murdock CJ, Kyles AE, Yeung-Lai-Wah JA, Qi A, Vorderbrugg S, Kerr CR. Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol 1990;66:755-757.
17. Falk RH. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med 1989;111:107-111.